CA Stock MarketDetailed Quotes

LABS MediPharm Labs Corp

Watchlist
  • 0.090
  • 0.0000.00%
15min DelayMarket Closed Apr 25 16:00 ET
37.00MMarket Cap-3.00P/E (TTM)

MediPharm Labs Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
60.60%-4.86M
-172.39%-1.07M
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
Net income from continuing operations
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
56.37%-13.08M
50.31%-2.79M
45.44%-4.33M
67.94%-2.88M
58.59%-3.09M
Operating gains losses
-229.00%-347K
10.00%-9K
-94.74%2K
-108.90%-21K
-6,480.00%-319K
-70.47%269K
-100.91%-10K
103.16%38K
-82.28%236K
101.58%5K
Depreciation and amortization
3.34%2.6M
-21.76%561K
-16.05%518K
5.64%731K
61.22%790K
-12.40%2.52M
32.78%717K
-18.17%617K
-8.83%692K
-40.17%490K
Asset impairment expenditure
-73.36%466K
-77.60%97K
-110.20%-31K
-83.60%166K
--234K
27.76%1.75M
138.52%433K
-84.58%304K
--1.01M
--0
Remuneration paid in stock
95.68%-83K
-154.17%-26K
--0
82.76%-80K
101.49%23K
-1,534.33%-1.92M
129.81%48K
-86.44%40K
---464K
---1.55M
Remuneration paid in stock
-51.85%976K
-314.05%-655K
-58.55%160K
-2.04%576K
19.81%895K
-29.42%2.03M
-77.99%306K
139.75%386K
1.38%588K
0.81%747K
Other non cashItems
107.75%569K
62.75%-130K
137.07%585K
103.48%180K
73.06%-66K
-1,420.70%-7.35M
-46.64%-349K
-1,260.34%-1.58M
-6,208.54%-5.17M
-421.28%-245K
Change In working capital
-52.12%1.65M
-73.65%821K
-31.83%878K
62.66%-575K
-9.90%528K
-44.70%3.45M
-20.85%3.12M
-59.47%1.29M
-0.33%-1.54M
-11.08%586K
-Change in receivables
-124.35%-1.56M
-113.74%-793K
-105.65%-473K
-64.56%319K
-2,700.00%-616K
77.74%6.42M
318.87%5.77M
-314.95%-230K
1,204.35%900K
-101.07%-22K
-Change in inventory
-74.37%798K
262.57%620K
-90.08%221K
107.68%37K
-106.68%-80K
3,123.30%3.11M
-85.48%171K
21.96%2.23M
78.05%-482K
231.50%1.2M
-Change in payables and accrued expense
136.14%1.87M
102.45%31K
146.04%553K
68.43%-601K
336.68%1.88M
-446.48%-5.17M
-269.80%-1.27M
-439.27%-1.2M
-535.70%-1.9M
-1,668.89%-796K
-Change in other current assets
112.83%137K
130.43%420K
-53.28%377K
-37.65%-819K
59.00%159K
-160.89%-1.07M
-291.93%-1.38M
-30.61%807K
-54.15%-595K
-61.24%100K
-Change in other working capital
175.33%413K
398.35%543K
163.49%200K
----
-872.64%-819K
--150K
---182K
---315K
----
--106K
Cash from discontinued investing activities
Operating cash flow
60.60%-4.86M
-172.39%-1.07M
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
Investing cash flow
Cash flow from continuing investing activities
-93.99%413K
-101.02%-44K
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
Capital expenditure reported
67.30%-154K
63.03%-44K
87.31%-33K
16.42%-56K
16.00%-21K
45.42%-471K
61.49%-119K
17.72%-260K
28.72%-67K
82.64%-25K
Net PPE purchase and sale
94.94%347K
--0
--0
--21K
--326K
--178K
2,642.86%178K
--0
--0
--0
Net business purchase and sale
--0
--0
--0
----
----
-12.50%5.26M
-29.35%4.25M
--0
----
----
Net other investing changes
-88.44%220K
--0
----
--0
--220K
27,085.71%1.9M
--0
--1.9M
----
----
Cash from discontinued investing activities
Investing cash flow
-93.99%413K
-101.02%-44K
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
Financing cash flow
Cash flow from continuing financing activities
-401.90%-1.85M
-1.24%-244K
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
Net issuance payments of debt
-138.56%-2.25M
13.81%-337K
-477.84%-2.24M
-40.40%596K
76.91%-269K
-340.20%-944K
27.32%-391K
-40.07%-388K
-21.26%1M
-1,779.03%-1.17M
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--14K
----
----
----
----
--0
----
----
----
----
Interest paid (cash flow from financing activities)
-13.64%-300K
75.32%-19K
-75.29%-149K
-13.27%-111K
-425.00%-21K
-915.38%-264K
-196.15%-77K
-4,350.00%-85K
-4,800.00%-98K
---4K
Net other financing activities
-17.74%691K
-56.83%98K
-2.87%169K
5.82%200K
-10.40%224K
95.80%840K
37.58%227K
31.82%174K
125.00%189K
420.83%250K
Cash from discontinued financing activities
Financing cash flow
-401.90%-1.85M
-1.24%-244K
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
Net cash flow
Beginning cash position
-25.53%17.98M
1.10%13.09M
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-29.21%24.15M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
Current changes in cash
-7.88%-6.3M
-124.45%-1.36M
-54.50%-2.92M
82.60%-956K
73.29%-1.07M
42.31%-5.84M
7.84%5.54M
43.57%-1.89M
10.64%-5.49M
30.64%-4M
Effect of exchange rate changes
101.22%4K
90.78%-47K
-81.25%18K
-75.29%21K
--12K
-319.33%-329K
-14.09%-510K
-88.12%96K
163.43%85K
--0
End cash Position
-34.99%11.69M
-34.99%11.69M
1.10%13.09M
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-25.53%17.98M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
Free cash from
60.85%-5.02M
-181.99%-1.11M
80.10%-695K
78.12%-1.66M
49.71%-1.55M
24.34%-12.81M
384.07%1.36M
-9.02%-3.49M
-1.21%-7.6M
46.47%-3.08M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 60.60%-4.86M-172.39%-1.07M79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M
Net income from continuing operations 18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M56.37%-13.08M50.31%-2.79M45.44%-4.33M67.94%-2.88M58.59%-3.09M
Operating gains losses -229.00%-347K10.00%-9K-94.74%2K-108.90%-21K-6,480.00%-319K-70.47%269K-100.91%-10K103.16%38K-82.28%236K101.58%5K
Depreciation and amortization 3.34%2.6M-21.76%561K-16.05%518K5.64%731K61.22%790K-12.40%2.52M32.78%717K-18.17%617K-8.83%692K-40.17%490K
Asset impairment expenditure -73.36%466K-77.60%97K-110.20%-31K-83.60%166K--234K27.76%1.75M138.52%433K-84.58%304K--1.01M--0
Remuneration paid in stock 95.68%-83K-154.17%-26K--082.76%-80K101.49%23K-1,534.33%-1.92M129.81%48K-86.44%40K---464K---1.55M
Remuneration paid in stock -51.85%976K-314.05%-655K-58.55%160K-2.04%576K19.81%895K-29.42%2.03M-77.99%306K139.75%386K1.38%588K0.81%747K
Other non cashItems 107.75%569K62.75%-130K137.07%585K103.48%180K73.06%-66K-1,420.70%-7.35M-46.64%-349K-1,260.34%-1.58M-6,208.54%-5.17M-421.28%-245K
Change In working capital -52.12%1.65M-73.65%821K-31.83%878K62.66%-575K-9.90%528K-44.70%3.45M-20.85%3.12M-59.47%1.29M-0.33%-1.54M-11.08%586K
-Change in receivables -124.35%-1.56M-113.74%-793K-105.65%-473K-64.56%319K-2,700.00%-616K77.74%6.42M318.87%5.77M-314.95%-230K1,204.35%900K-101.07%-22K
-Change in inventory -74.37%798K262.57%620K-90.08%221K107.68%37K-106.68%-80K3,123.30%3.11M-85.48%171K21.96%2.23M78.05%-482K231.50%1.2M
-Change in payables and accrued expense 136.14%1.87M102.45%31K146.04%553K68.43%-601K336.68%1.88M-446.48%-5.17M-269.80%-1.27M-439.27%-1.2M-535.70%-1.9M-1,668.89%-796K
-Change in other current assets 112.83%137K130.43%420K-53.28%377K-37.65%-819K59.00%159K-160.89%-1.07M-291.93%-1.38M-30.61%807K-54.15%-595K-61.24%100K
-Change in other working capital 175.33%413K398.35%543K163.49%200K-----872.64%-819K--150K---182K---315K------106K
Cash from discontinued investing activities
Operating cash flow 60.60%-4.86M-172.39%-1.07M79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M
Investing cash flow
Cash flow from continuing investing activities -93.99%413K-101.02%-44K-102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K
Capital expenditure reported 67.30%-154K63.03%-44K87.31%-33K16.42%-56K16.00%-21K45.42%-471K61.49%-119K17.72%-260K28.72%-67K82.64%-25K
Net PPE purchase and sale 94.94%347K--0--0--21K--326K--178K2,642.86%178K--0--0--0
Net business purchase and sale --0--0--0---------12.50%5.26M-29.35%4.25M--0--------
Net other investing changes -88.44%220K--0------0--220K27,085.71%1.9M--0--1.9M--------
Cash from discontinued investing activities
Investing cash flow -93.99%413K-101.02%-44K-102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K
Financing cash flow
Cash flow from continuing financing activities -401.90%-1.85M-1.24%-244K-643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K
Net issuance payments of debt -138.56%-2.25M13.81%-337K-477.84%-2.24M-40.40%596K76.91%-269K-340.20%-944K27.32%-391K-40.07%-388K-21.26%1M-1,779.03%-1.17M
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees --14K------------------0----------------
Interest paid (cash flow from financing activities) -13.64%-300K75.32%-19K-75.29%-149K-13.27%-111K-425.00%-21K-915.38%-264K-196.15%-77K-4,350.00%-85K-4,800.00%-98K---4K
Net other financing activities -17.74%691K-56.83%98K-2.87%169K5.82%200K-10.40%224K95.80%840K37.58%227K31.82%174K125.00%189K420.83%250K
Cash from discontinued financing activities
Financing cash flow -401.90%-1.85M-1.24%-244K-643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K
Net cash flow
Beginning cash position -25.53%17.98M1.10%13.09M8.47%15.99M-16.00%16.93M-25.53%17.98M-29.21%24.15M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M
Current changes in cash -7.88%-6.3M-124.45%-1.36M-54.50%-2.92M82.60%-956K73.29%-1.07M42.31%-5.84M7.84%5.54M43.57%-1.89M10.64%-5.49M30.64%-4M
Effect of exchange rate changes 101.22%4K90.78%-47K-81.25%18K-75.29%21K--12K-319.33%-329K-14.09%-510K-88.12%96K163.43%85K--0
End cash Position -34.99%11.69M-34.99%11.69M1.10%13.09M8.47%15.99M-16.00%16.93M-25.53%17.98M-25.53%17.98M-33.43%12.95M-32.97%14.74M-28.73%20.15M
Free cash from 60.85%-5.02M-181.99%-1.11M80.10%-695K78.12%-1.66M49.71%-1.55M24.34%-12.81M384.07%1.36M-9.02%-3.49M-1.21%-7.6M46.47%-3.08M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More